Our work showed that climbing stairs is pretty good! Associated with a 39% cardiovascular death reduction and 24% overall mortality. Thankful to @SophiePaddock @RathnaVeerni @CardioShades @justvick Emily and James! link.springer.com/article/10… @SpringerNature CHOOSE STAIRS!

📊 From the TriNetX global cohort (381K adults): 💊 Tirzepatide users showed: •🔻 47% lower HF risk •🔻 69% lower mortality •🔻 54% fewer MACE 📄 Strong evidence for HF prevention in obesity. 🔗 tinyurl.com/4296nt83

📢 Join us for another edition of the Journal Club in collaboration with EACVI! ⏳ 27 th of November 2025 17:00 CET 🎯 We'll be discussing Socio-economic status, cardiovascular risk factors, and coronary atherosclerosis: a SCOT-HEART trial analysis, Jonathan R Weir-McCall et al. EJPC (March 2025) together with Professor Mark Dweck and Doctor Edoardo Conte Registration is open to everyone! esc365.escardio.org/event/21…

New in #EJPC: “Therapies leading to coronary atherosclerosis plaque regression” a joint scientific statement by #EAPC, #EACVI, and ESC WGs on Atherosclerosis&Pharmacotherapy. 🧬 Part 1 dives into atherosclerosis pathophysiology and imaging evaluation. 🔗 tinyurl.com/6rtrrtfs

📢 New in #EJPC: “Differences in long-term impact of traditional risk factors for atherosclerosis on different arterial territories” insights from over 20 years of follow-up in the EPIC-Norfolk study ow.ly/sL1E50XiX1O @EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @justvick

The present issue of the #EJPC is focused on the interplay between #pulmonary conditions and #cardiovascular consequences, and how to prevent them. 🔗academic.oup.com/eurjpc/issu…

New data from >4 million adults in Japan show that while sleep apnoea syndrome (SAS) is less common in women, 💤 it confers a higher cardiovascular risk in women than in men. Sex-specific strategies are needed for early detection and prevention. tinyurl.com/4ejk33vn

“What gets us into trouble is not what we don't know. It's what we know for sure that just ain't so”. Don’t miss this must-read #EJPC editorial on rethinking the #obesityparadigm. ➡️Not all extra weight tells the same story. In patients with STEMI, overweight & mild obesity showed lower mortality than normal weight, while only severe obesity was associated with risk. ➡️ Body weight impact is context-dependent. academic.oup.com/eurjpc/adva…

Daily flavan-3-ol intake (tea 🍵, cocoa 🍫, apples 🍎, grapes 🍇) 📉 lowers BP especially when elevated 💪 improves vascular function 🩺 A promising ally in CV prevention tinyurl.com/y9e5zxpj

Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association. Read more in #EHJ 👉 ow.ly/uisk50Xe3mR @RoccoMontone @ehj_ed #amyloidosis

🔍How does your BP history shape your heart? ✅10-yr cumulative SBP→ ↑LV mass, ↓myocardial strain ✅ Long-term BP matters even without HT ✅ Impaired function & fibrosis risk ↑ independently of today's BP 🧠 Time-integrated BP=a key CV risk marker 🔗 shorturl.at/88kDc

Looking forward to welcoming you in April at #ESCPrev26 💚  Step into the heart of #cvprev by registering early for the best savings, and submit your abstract by 20 Nov and clinical case by 27 Nov. 🔗Submit: escardio.org/Congresses-Even… 🔗Register: escardio.org/Congresses-Even… @RitaPintoUL @SMosteoru #EAPC_ESC

Join us in Ljubljana, we are preparing a memorable and packed #ESCPrev26 in the beautiful capital of 🇸🇮 #cvprev #cardiotwitter @justvick @PeroneFrancesco @EJPCEiC @ESC_Journals @Ajar_kocak @DrMarthaGulati @unilj @SMosteoru

Sex-specific associations between blood pressure in early midlife and arterial stiffness 27 years later: the Hordaland Health Study” published in #EJPC highlighting how midlife BP can shape vascular health decades down the line ow.ly/a4vK50XeKP9 @EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @justvick

❤️ Can a breath test predict your heart risk? An increased expiratory CO level on admission flagged: ❗ 3x higher 1-year mortality ❗ 6x ↑ risk of in-hospital MAEs ❗ A top-ranked predictor via machine learning ⛔️ CO: a silent signal—beyond smoking shorturl.at/JC3YG

⬆️Lp(a) levels are independently associated with subclinical coronary atherosclerosis in ageing endurance athletes and healthy controls even with low conventional CV risk. 👉 Highlights the value of Lp(a) for risk stratification in low-risk populations. tinyurl.com/36yrv7tj

🩺💻 A #telemedicine-based lipid-lowering strategy helped 82.6% of post-ACS patients reach LDL-c targets (<55 mg/dL) in just 3.2 months with improved #lipidcontrol and reduced #cardiovascular mortality. 🔗 tinyurl.com/kew86u62

Super presentation on TV and the R Heart by @denisamuraru at @BSEcho . Valuable insights on eRVEF & also which patients with moderate TR to refer to Heart Valve Centres @BSE_President @dr_benoy_n_shah @justvick @AVamvakidou @melanieackrill #bsecho2025

💥 The “Global Leadership Initiative on Sarcopenia (GLIS)” model redefines sarcopenia not just by muscle mass or strength, but by clinical outcomes. 🏥 In 891 older HF patients, GLIS-defined sarcopenia=3.4×⬆️ 2-year mortality. 🚨 Prognosis matters! 🔗 tinyurl.com/37h25pja

Mitral annular dysjunction-associated fibrosis on #WhyCMR 🩻 Learn how to spot scar in this condition in this excellent paper published in @EHJIMPEiC 🤩 1/4 patients with MAD = basal inferolateral scar @alessia_gimelli @VDelgadoGarcia @pabloplopez_ academic.oup.com/ehjimp/arti…